Valencia, Guillermo Arturo Neciosup, Silvia Gómez, Henry L Benites, Maria Del Pilar Falcón, Silvia Moron, David Veliz, Karin Maldonado, Mike Auqui, Rodrigo
Published in
World Journal of Clinical Oncology
BACKGROUND The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (a novel coronavirus), which was first identified amid an outbreak of respiratory illness cases in Wuhan, China and declared a global health emergency, is currently considered an additional challenge in the management of patients wi...
Barros, José Máximo Rizzo, Manglio Miguel Chiozza, Jorge Oscar Couñago, Felipe
Published in
World Journal of Clinical Oncology
Thoracic radiotherapy (TRT) is one of the main treatments in limited-stage small cell lung cancer (LS-SCLC). Hyperfractionated TRT (45 Gy, 1.5 Gy twice daily) has been the standard of care (SOC) since Turrisi and colleagues published the results of their clinical trial in 1999. Two meta-analyses have demonstrated the benefits of concurrent chemothe...
Mehdipour, Parvin Javan, Firoozeh Jouibari, Morteza Faghih Khaleghi, Mehdi Mehrazin, Masoud
Published in
World Journal of Clinical Oncology
BACKGROUND Although circulating tumor cells (CTCs) have been the focus of consideration for a decade, a categorized cell-based diagnostic strategy is unavailable. The personalized management and complementary/analytical-strategy of data require an alphabetic guide. Therefore, we aimed to determine the behavior of CTCs in tumor and blood in order to...
Henriquez, Ivan Spratt, Daniel Gómez-Iturriaga, Alfonso Abuchaibe, Oscar Couñago, Felipe
Published in
World Journal of Clinical Oncology
Nonmetastatic castration-resistant prostate cancer (nmCRPC) - defined as prostate-specific antigen (PSA) > 2 ng/mL, testosterone castration levels
Stuckey, Ruth López-Rodríguez, Juan Francisco Sánchez-Sosa, Santiago Segura-Díaz, Adrián Sánchez-Farías, Nuria Bilbao-Sieyro, Cristina Gómez-Casares, María Teresa
Published in
World Journal of Clinical Oncology
Clinical trials have demonstrated that some patients with chronic myeloid leukemia (CML) treated for several years with tyrosine kinase inhibitors (TKIs) who have maintained a molecular response can successfully discontinue treatment without relapsing. Treatment free remission (TFR) can be reached by approximately 50% of patients who discontinue. D...
Deac, Andrada Larisa Burz, Claudia Cristina Bocsan, Ioana Corina Buzoianu, Anca Dana
Published in
World Journal of Clinical Oncology
Cardio-oncology is a discipline based on early screening, monitoring, and treating chemotherapy-induced cardiotoxicity. There are many chemotherapeutics known for their cardiac toxic effects, including fluoropyrimidines. Fluoropyrimidine represents the cornerstone of many types of cancer and each year almost two million cancer patients undergo this...
Solé, Sebastián Baeza, Ramón Gabler, Carolina Couñago, Felipe
Published in
World Journal of Clinical Oncology
In the following review we intend to ascertain the optimal neoadjuvant therapy in patients with locally advanced rectal cancer. In 2004, a study revealed that chemoradiotherapy (CRT) resulted in better local control when performed preoperatively rather than postoperatively, thus neoadjuvant treatment was established as a standard treatment. Subsequ...
Strojnik, Tadej Kavalar, Rajko Gornik-Kramberger, Kristina Rupnik, Maja Robnik, Slavica Lorencic Popovic, Mara Velnar, Tomaz
Published in
World Journal of Clinical Oncology
BACKGROUND The gram-negative aerobic bacterium Moraxella osloensis is an opportunistic pathogen in brain tissues. CASE SUMMARY The gram-negative aerobic bacterium Moraxella osloensis was isolated from a patient’s brain tissue during a stereotactic biopsy. CONCLUSION This is the first report of a brain tissue infection with Moraxella osloensis possi...
Mielgo-Rubio, Xabier Garde-Noguera, Javier Juan, Oscar Couñago, Felipe
Published in
World Journal of Clinical Oncology
The European Organization for Research on Treatment of Cancer Research published a consensus statement to establish the key criteria to define oligometastatic disease (OMD). According to those criteria, all lesions (both primary and metastatic) should be amenable to radical intent treatment with acceptable toxicity. Several retrospective studies ha...
Taylor, Zachary C Kaya, Erin A Bunn, Jeffrey D Guss, Zachary D Mitchell, Brian J Fairbanks, Robert K Lamoreaux, Wayne T Wagner, Aaron E Peressini, Ben J Lee, Christopher M
...
Published in
World Journal of Clinical Oncology
BACKGROUND Mucoepidermoid carcinoma (MEC) is a rare malignancy of the head and neck; however, it accounts for a majority of the tumors of the salivary glands. This study used a national population-based registry to describe the pre-treatment and treatment-related prognostic factors that influence survival in patients with MEC of the major salivary ...
